Trial Profile
Clinical Trials Insight: 700028770
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2007
Price :
$35
*
At a glance
- Drugs Irbesartan/hydrochlorothiazide (Primary) ; Hydrochlorothiazide; Irbesartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 26 Nov 2007 New trial record.